Skip to main content
. Author manuscript; available in PMC: 2019 Aug 21.
Published in final edited form as: J Mater Chem B. 2018 Jul 25;6(31):5080–5090. doi: 10.1039/C8TB00804C

Fig. 11.

Fig. 11

Relative uptake efficiency of NGO/DOX@SPC-FA in Hela cells pre-treated with various endocytosis inhibitors at 37°. CPZ treatment resulted in the decrease of 80% DOX uptake. AMI treatment led to a decrease of cellular uptake of DOX. M-β-CD treatment did not show any effect on nanohybrids uptake. *P<0.05, ***P<0.001 versus their respective control. Data are presented as mean ±SD (n = 3).